Study results published in Pediatrics showed that adverse social determinants of health (SDOH) were significantly associated with increased at-risk rates (ARRs) of pediatric asthma morbidity and that these ARRs varied widely across census tracts in Washington, DC.1
Researchers aimed to evaluate the associations between pediatric asthma morbidity and SDOH in the different census tracts using ARRs, which account for underlying variations in asthma prevalence. They calculated ARRs for pediatric asthma-related emergency department (ED) visits and hospitalizations based on the number of children with asthma in each tract of the city. Examining the associations between census-tract ARRs and SDOH allows for the identification of specific place-based SDOH that could be targeted to reduce pediatric asthma morbidity.
ARRs are preferable to using population-based rates (PBRs) in geospatial analyses because the former divide ED visits and hospitalizations by only children with asthma in a particular area, whereas PBRs divide these encounters by all children in a particular area. As ARRs are calculated using only those at risk for pediatric asthma-related morbidity, census-tract ARRs may more accurately evaluate the effect of SDOH on disparities in pediatric asthma morbidity. To the researchers’ knowledge, this is the first study to use ARRs in order to evaluate associations between pediatric asthma morbidity and SDOH.
This population-based, cross-sectional study included children with asthma aged 2 to 17 years and residing in Washington, DC. Researchers pulled data from the DC Pediatric Asthma Registry. Health records from January 2018 to December 2019 were analyzed.
ARRs were calculated by dividing the number of ED encounters and hospitalizations by the number of children with asthma in each census tract.
Researchers used the Healthy People 2030 SDOH framework to determine 5 census-tract exposure variables: educational attainment, vacant housing, violent crime, limited English proficiency, and families living in poverty.
During the study, 4321 children with asthma had 7515 total ED encounters and 1182 children with asthma had 1588 total hospitalizations.
Across DC census tracts, ARRs for both ED encounters and hospitalizations varied greater than 10-fold. For ED encounters, ARRs ranged from 64 to 728 per 1000 children with asthma, depending on the census tract. ARRs for hospitalizations ranged from 20 to 240 per 1000 children with asthma, depending on the census tract.
Simple linear regression analyses showed that an increase in vacant housing, poverty, and violent crime and a decrease in educational attainment was associated with an increase in ARRs for ED encounters. These analyses also showed decreased educational attainment, poverty, and adults with limited English proficiency to be associated with increased ARRs for hospitalizations.
Multivariable linear regression analyses showed decreased educational attainment to be significantly associated with increased ARRs for ED encounters and for hospitalizations. Increased violent crime was significantly associated with increased ARRs for ED encounters.
Limitations of this study include the cross-sectional design, which prohibited researchers from evaluating potential causality between SDOH and pediatric asthma morbidity. Another limitation is that SDOH beyond the 5 evaluated in this study may be important factors related to pediatric asthma morbidity. In addition, the study population did not encompass all children with asthma in DC and asthma severity was not measured. Finally, ecological fallacy may have occurred, meaning that the aggregate data may not accurately reflect an individual living in a particular area.
Data from this study may be helpful in creating location-specific interventions to address SDOH in order to reduce pediatric asthma morbidity, the researchers concluded.
In an accompanying editorial, Lara J. Akinbami, MD, and Tyra Bryant-Stephens, MD, call the research “a renewed call to action,” noting that the authors’ work to identify contextual risk factors has provided “a more meaningful methodology for measuring and mapping risk and outcomes at the census tract level and working for change.”2
References
1. Tyris J, Gourishankar A, Ward MC, Kachroo N, Teach SJ, Parikh K. Social determinants of health and at-risk rates for pediatric asthma morbidity. Pediatrics. 2022;150(2).
2. Akinbami LJ, Bryant-Stephens T. Increasing the resolution and broadening the focus on childhood asthma disparities. Pediatrics. 2022;150(2). doi:10.1542/peds.2022-057206
Social Determinants of Health Associated With Asthma Morbidity in Children
At-risk rates of asthma morbidity in children varied across census tracts in Washington, DC, and were significantly correlated with social determinants of health in each area, according to a recent study.
Study results published in Pediatrics showed that adverse social determinants of health (SDOH) were significantly associated with increased at-risk rates (ARRs) of pediatric asthma morbidity and that these ARRs varied widely across census tracts in Washington, DC.1
Researchers aimed to evaluate the associations between pediatric asthma morbidity and SDOH in the different census tracts using ARRs, which account for underlying variations in asthma prevalence. They calculated ARRs for pediatric asthma-related emergency department (ED) visits and hospitalizations based on the number of children with asthma in each tract of the city. Examining the associations between census-tract ARRs and SDOH allows for the identification of specific place-based SDOH that could be targeted to reduce pediatric asthma morbidity.
ARRs are preferable to using population-based rates (PBRs) in geospatial analyses because the former divide ED visits and hospitalizations by only children with asthma in a particular area, whereas PBRs divide these encounters by all children in a particular area. As ARRs are calculated using only those at risk for pediatric asthma-related morbidity, census-tract ARRs may more accurately evaluate the effect of SDOH on disparities in pediatric asthma morbidity. To the researchers’ knowledge, this is the first study to use ARRs in order to evaluate associations between pediatric asthma morbidity and SDOH.
This population-based, cross-sectional study included children with asthma aged 2 to 17 years and residing in Washington, DC. Researchers pulled data from the DC Pediatric Asthma Registry. Health records from January 2018 to December 2019 were analyzed.
ARRs were calculated by dividing the number of ED encounters and hospitalizations by the number of children with asthma in each census tract.
Researchers used the Healthy People 2030 SDOH framework to determine 5 census-tract exposure variables: educational attainment, vacant housing, violent crime, limited English proficiency, and families living in poverty.
During the study, 4321 children with asthma had 7515 total ED encounters and 1182 children with asthma had 1588 total hospitalizations.
Across DC census tracts, ARRs for both ED encounters and hospitalizations varied greater than 10-fold. For ED encounters, ARRs ranged from 64 to 728 per 1000 children with asthma, depending on the census tract. ARRs for hospitalizations ranged from 20 to 240 per 1000 children with asthma, depending on the census tract.
Simple linear regression analyses showed that an increase in vacant housing, poverty, and violent crime and a decrease in educational attainment was associated with an increase in ARRs for ED encounters. These analyses also showed decreased educational attainment, poverty, and adults with limited English proficiency to be associated with increased ARRs for hospitalizations.
Multivariable linear regression analyses showed decreased educational attainment to be significantly associated with increased ARRs for ED encounters and for hospitalizations. Increased violent crime was significantly associated with increased ARRs for ED encounters.
Limitations of this study include the cross-sectional design, which prohibited researchers from evaluating potential causality between SDOH and pediatric asthma morbidity. Another limitation is that SDOH beyond the 5 evaluated in this study may be important factors related to pediatric asthma morbidity. In addition, the study population did not encompass all children with asthma in DC and asthma severity was not measured. Finally, ecological fallacy may have occurred, meaning that the aggregate data may not accurately reflect an individual living in a particular area.
Data from this study may be helpful in creating location-specific interventions to address SDOH in order to reduce pediatric asthma morbidity, the researchers concluded.
In an accompanying editorial, Lara J. Akinbami, MD, and Tyra Bryant-Stephens, MD, call the research “a renewed call to action,” noting that the authors’ work to identify contextual risk factors has provided “a more meaningful methodology for measuring and mapping risk and outcomes at the census tract level and working for change.”2
References
1. Tyris J, Gourishankar A, Ward MC, Kachroo N, Teach SJ, Parikh K. Social determinants of health and at-risk rates for pediatric asthma morbidity. Pediatrics. 2022;150(2).
2. Akinbami LJ, Bryant-Stephens T. Increasing the resolution and broadening the focus on childhood asthma disparities. Pediatrics. 2022;150(2). doi:10.1542/peds.2022-057206
The Health-Related Consequences of Redlining
October 3rd 2024The legacy of redlining continues to harm minority health, with Black individuals facing higher rates of health issues, linked to environmental factors and limited access to resources in regions previously redlined.
Read More
Advancements in Asthma Treatment: Next Steps and Insights From Clinical Development of Rilzabrutinib
August 1st 2024Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, outlines future steps for the clinical development of rilzabrutinib, as well as promising data to advance to phase 3 studies.
Read More
What We’re Reading: COVID-19 Vaccine and Fewer Asthma Symptoms; Cyberattack Reporting Rule; MA Misdiagnoses Drive Up Costs
July 8th 2024Researchers link vaccination and reduced asthma symptoms; providers warn against overburdening and security risks; insurers’ practices lead to questionable diagnoses
Read More
A Breathtaking Crisis, Part 2: Climate Change Worsens Asthma for Underserved Communities
July 3rd 2024Underserved communities, already facing higher asthma prevalence due to social determinants of health, are disproportionately affected by the impact climate change is having on asthma exacerbations. Potential solutions include education for patients and health care providers, climate litigation to establish environmental rights, and policy changes to curb climate change.
Read More
A Breathtaking Crisis, Part 1: Climate Change Worsens Asthma
June 30th 2024Asthma is worsening under the effects of climate change, such as air pollution and pollen production, especially for underserved populations.
Read More
Rilzabrutinib Improves Asthma Symptoms in the First 2 Weeks of Treatment, Study Finds
June 28th 2024Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, discusses efficacy outcomes in patients with asthma who received rilzabrutinib.
Read More
The Health-Related Consequences of Redlining
October 3rd 2024The legacy of redlining continues to harm minority health, with Black individuals facing higher rates of health issues, linked to environmental factors and limited access to resources in regions previously redlined.
Read More
Advancements in Asthma Treatment: Next Steps and Insights From Clinical Development of Rilzabrutinib
August 1st 2024Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, outlines future steps for the clinical development of rilzabrutinib, as well as promising data to advance to phase 3 studies.
Read More
What We’re Reading: COVID-19 Vaccine and Fewer Asthma Symptoms; Cyberattack Reporting Rule; MA Misdiagnoses Drive Up Costs
July 8th 2024Researchers link vaccination and reduced asthma symptoms; providers warn against overburdening and security risks; insurers’ practices lead to questionable diagnoses
Read More
A Breathtaking Crisis, Part 2: Climate Change Worsens Asthma for Underserved Communities
July 3rd 2024Underserved communities, already facing higher asthma prevalence due to social determinants of health, are disproportionately affected by the impact climate change is having on asthma exacerbations. Potential solutions include education for patients and health care providers, climate litigation to establish environmental rights, and policy changes to curb climate change.
Read More
A Breathtaking Crisis, Part 1: Climate Change Worsens Asthma
June 30th 2024Asthma is worsening under the effects of climate change, such as air pollution and pollen production, especially for underserved populations.
Read More
Rilzabrutinib Improves Asthma Symptoms in the First 2 Weeks of Treatment, Study Finds
June 28th 2024Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, discusses efficacy outcomes in patients with asthma who received rilzabrutinib.
Read More